RedHill Biopharma Ltd. (RDHL) NASDAQ
0.80
-0.2199(-21.56%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.25M |
| Enterprise Value | 352,950 |
| P/E Ratio | -0.21 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0.37 |
| Price/Book Ratio | 0.34 |
| Enterprise/Revenue | -0.06 |
| Enterprise/EBITDA | 0.06 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -0.99 |
| Operating Margin | -1.09 |
Management Effectiveness
| Return On Assets | -0.27 |
| Return On Equity | 2.91 |
Income Statement
| Revenue | 286,000 |
| Revenue/Share | 3.78 |
| Gross Profit | 286,000 |
| EBITDA | -7.65M |
| Net Income | -429,000 |
| Diluted EPS | 0 |
Balance Sheet
| Total Cash | 3.97M |
| Total Cash/Share | 2.2 |
| Total Debt | 1.07M |
| Total Debt/Equity | 0.25 |
| Current Ratio | 0.34 |
| Book Value Per Share | 2.37 |
Price History
| 52-Week Change | -60.97 |
| 52-Week High | 3.31 |
| 52-Week Low | 0.71 |
| Moving Average 50 Days | 0.93 |
| Moving Average 200 Days | 1.19 |
Statistics
| Average Volume | 64,858 |
| Shares Outstanding | 3.14M |
| % Held by Institutions | 0.01 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | August 20, 2024 |
